| 326 |
Cidofovir
|
-
Cidofovir, CAS-RN: 113852-37-2, DTXSID3043734
|
256: Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
|
| 864 |
Chrysene
|
-
Chrysene, CAS-RN: 218-01-9, DTXSID0022432
|
3 AOPs
|
| 713 |
Chromium
|
-
Chromium, CAS-RN: 7440-47-3, DTXSID3031022
|
None
|
| 243 |
Chromafenozide
|
-
Chromafenozide, CAS-RN: 143807-66-3, DTXSID4057976
|
2 AOPs
|
| 787 |
Cholinergic drugs
|
|
551: Increased Muscarinic M2 Receptor leading to Arrhythmia
|
| 680 |
Cholesterol
|
-
Cholesterol, CAS-RN: 57-88-5, DTXSID3022401
|
None
|
| 356 |
Chlorzoxazone
|
-
Chlorzoxazone, CAS-RN: 95-25-0, DTXSID9022813
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 766 |
Chlorpyrifos oxon
|
-
Chlorpyrifos oxon, CAS-RN: 5598-15-2, DTXSID1038666
|
490: Co-activation of IP3R and RyR leads to reduced IQ and increased socio-economic burden through non-cholinergic mechanisms
|
| 280 |
Chlorpyrifos
|
-
Chlorpyrifos, CAS-RN: 2921-88-2, DTXSID4020458
|
3 AOPs
|
| 117 |
Chlorpromazine
|
-
Chlorpromazine, CAS-RN: 50-53-3, DTXSID0022808
|
None
|
| 856 |
Chlorotoluron
|
-
Chlorotoluron, CAS-RN: 15545-48-9, DTXSID8052853
|
567: Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition
|
| 389 |
Chloroquine bis(phosphate)
|
-
Chloroquine bis(phosphate), CAS-RN: 50-63-5, DTXSID7044681
|
144: Endocytic lysosomal uptake leading to liver fibrosis
|
| 198 |
chlorophacinone
|
-
Chlorophacinone, CAS-RN: 3691-35-8, DTXSID2032348
|
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 142 |
Chloroform
|
-
Chloroform, CAS-RN: 67-66-3, DTXSID1020306
|
None
|
| 473 |
CHIR99021
|
|
None
|
| 478 |
CHIR98014
|
|
None
|
| 480 |
CHIR-99021
|
-
CHIR-99021, CAS-RN: 252917-06-9, DTXSID90179931
|
None
|
| 481 |
CHIR-98014
|
|
None
|
| 355 |
Chemical:584015 (1-~13~C)Aniline
|
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 630 |
Chemical:33664 17-Methyltestosterone
|
|
376: Androgen receptor agonism leading to male-biased sex ratio
|
| 439 |
Chemical:20384 Dexamethasone, minocycline, innamicaldehyde
|
|
None
|
| 240 |
Chemical
|
|
205: AOP from chemical insult to cell death
|
| 507 |
Cetrorelix
|
-
Cetrorelix, CAS-RN: 120287-85-6, DTXSID7040996
|
309: Luteinizing hormone receptor antagonism leading to reproductive dysfunction
|
| 628 |
cell free mitochondrial DNA (mtDNA)
|
|
377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
|
| 86 |
Celecoxib
|
-
Celecoxib, CAS-RN: 169590-42-5, DTXSID0022777
|
177: Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality
|